FDA Clearance Tracker · P050052-S091
RADIESSE INJECTABLE IMPLANT (DERMAL FILLERS)
Last checked: Nov 20, 2026Latest source record: Apr 26, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Apr 26, 2017
Approved
Time to decision
98 days
Received Jan 18, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P050052-S091
- Device name
- RADIESSE INJECTABLE IMPLANT (DERMAL FILLERS)
- Applicant
- Merz North America, Inc.
- Applicant location
- Franksville, WI
- Received
- Jan 18, 2017
- Decided
- Apr 26, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P050052
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for changes to the protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Merz North America, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250016 · Decided Jul 9, 2026 · 387 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.